Drug Development Process Flashcards

1
Q

What is Step 1 in the drug development process

A

Discovery and Development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some of the things studied in the step 1 phase

A
  • How is a compound absorbed, metabolized, and excreted
  • Potential benefits and MOA
  • Best dosage
  • Best way to give the drug
  • Drug interactions
  • Effectiveness compared to other drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Step 2 in the drug development process

A

Preclinical research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two types of preclinical research

A

In vitro, in vivo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Data from which step in the drug development process will allow researchers to move on with human trials

A

Step 2: Preclinical research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Step 3 in the drug development process

A

Clinical Research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does IND stand for?

A

Investigational new drug process. This is the stage before human trials are allowed to begin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some of the things to consider when designing a study protocol?

A
  • Who qualifies to participate
  • How long will it last
  • How many participants
  • Whether there is a control group or what mechanisms are in place for limiting research bias
  • What assessments will be conducted, when, and what data will be collected
  • How the data will be reviewed and analyzed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the components of an IND application to the FDA?

A
  • Animal study data and toxicity
  • Manufacturing information
  • Clinical protocols (study plans)
  • Data from any prior human research
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the purpose of Phase 1 trials

A

Safety and dosage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Generally how many participants are in phase 1 trials

A

20 - 100 healthy volunteers with the disease or condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the duration of Phase 1

A

Several months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the purpose of Phase 2 trials

A

Efficacy and side effects. Typically trials isn’t large enough to determine efficacy, but will help to design phase 3 and establish a safety dosages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How many participate in Phase 2

A

Up to several hundred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the purpose of Phase 3

A

Efficacy and monitoring of side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How many participate in Phase 3

A

300 to 3000

17
Q

What is the duration of Phase 3

A

1 - 4 years

18
Q

What is the purpose of Phase 4

A

Safety and efficacy

19
Q

What is the FDA application after an IND

A

NDA. This will tell the full story of the drug and allow the manufacturer to market it. Once FDA approves, it will work with manufacturer on the labeling process

20
Q

Do generic drugs go through the same process as the initial sponsor?

A

No, they just need to conduct bio-equivalence studies and file a New Drug Application